HYUNDAI BIOSCIENCE
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Hyundai Bioscience announces XAFTY®, a groundbreaking broad-spectrum antiviral capable of treating COVID-19, mpox, and dengue 2024-09-11 14:25
An oral antiviral drug from Korea may be a problem solver for COVID-19 2021-05-13 16:37
1